BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
151 hedge funds and large institutions have $221M invested in BioDelivery Sciences International, Inc. in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 9 closing their positions.
145% more call options, than puts
Call options by funds: $4.02M | Put options by funds: $1.64M
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
20% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 45
6% more funds holding
Funds holding: 143 → 151 (+8)
5% more capital invested
Capital invested by funds: $210M → $221M (+$11.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$7.26M |
| 2 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$4.13M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.91M |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$1.16M |
| 5 |
Two Sigma Advisers
New York
|
+$884K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$5.33M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$3.28M |
| 3 |
RA
Royce & Associates
New York
|
-$2.38M |
| 4 |
DM
Deerfield Management
New York
|
-$1.36M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.13M |
BDSI Hedge Fund Activity: Q3 2021 in Review
151 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2021, worth a combined $221M — up 5.4% from $210M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BDSI positions and 9 closed out — a net gain of 8 holders — while 54 added to existing stakes and 45 trimmed.
The largest buyer was LSV Asset Management, opening a new position worth an estimated $7.26M. The largest seller was Goldman Sachs, cutting an estimated $5.33M.
- 151 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2021, up from 143 in Q2 2021.
- Funds reported $221M of BioDelivery Sciences International, Inc. stock for Q3 2021, up 5.4% quarter-over-quarter.
- 17 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2021 and 9 closed out, a net change of +8 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2021 was LSV Asset Management, an estimated $7.26M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2021 was Goldman Sachs, an estimated $5.33M sold.
Based on aggregated 13F filings for Q3 2021.